UnitedHealth Group Looks to Exit Latin America. Is This a Good Move for Investors, or a Sign of More Problems Ahead?

Shares of UnitedHealth Group have sold off considerably this year, as bad news surrounding the company continues to pile up.

On June 11, Baird downgraded UnitedHealth Group Incorporated (NYSE:UNH) to Neutral from Outperform, bringing the price target to $312 from $356.

New UnitedHealth Group CEO vows to 'earn back trust' after tumultuous year Stephen Hemsley previously served as CEO from 2006 through 2017 and has chaired the UnitedHealth Group board since 2017.

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make it a compelling buy-and-hold. Read more here.

UnitedHealth Group (NYSE: UNH) is central to the trillion-dollar U.S. healthcare industry. It's a behemoth that generates over $400 billion in annual revenue with insurance, pharmacy, care ...

In early April, market analysts touted UnitedHealth Group as a “tariff safe haven.” And why not? The Trump administration had just announced an increase in payments to Medicare Advantage plans ...

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- On May 15, 2025, investors in UnitedHealth Group (NYSE: UNH) saw the price of their shares crater as much as $59.13 (-19%) after The Wall Street ...

Two lawsuits accused UnitedHealth Group and its 401 (k) plan fiduciaries of violating ERISA by misusing employer matching funds forfeited by employees who left the company before being full vested.

UnitedHealth Group, one of America’s biggest corporations and a member of the exclusive Dow Jones Industrial Average, is suddenly unraveling.